
MANITOBA CLINICAL TRIALS
We would like to highlight the ongoing clinical trials occurring in Manitoba. Many of these trials are also occurring in other Canadian provinces.
​
COVID-19 PEP RCT - Canada (currently Quebec, Alberta, British Columbia, Ontario, and Manitoba)
-
PEP = Post-exposure prophylaxis
-
Study comparing hydroxychloroquine to placebo to determine if it is effective in preventing the onset or progression of COVID-19 disease.
-
Recruitment of:
-
Individuals ​with a confirmed diagnosis of COVID-19
-
Household member exposed to someone with COVID-19
-
Healthcare worker with high risk exposure to a COVID-19 case
-
-
Enrollment is online
-
For more information on the study and to enroll visit https://www.covid-19research.ca/home
​
PrEP for SARS-CoV-2 RCT - Canada (Manitoba and soon Quebec) in conjunction with the University of Minnesota
-
PrEP = Pre-exposure prophylaxis
-
Study to investigate whether hydroxychloroquine can help prevent COVID-19 disease
-
Recruitment of healthcare workers at high risk of of COVID-19 exposure
-
Individuals primarily ​working in emergency departments
-
Individuals primarily working in intensive care units
-
Individuals performing aerosol generating procedures
-
Individuals working in a long-term care facility with a previous or current outbreak of COVID-19
-
First responders
-
-
For more information on the study and to enroll visit https://covidpreptrial.ca
​
​